HLA-A*24020102L in the UK blood donor population

被引:5
作者
Dunn, PPJ
Turton, JR
Downing, J
Williams, S
Navarrete, CV
Darke, C
机构
[1] Natl Blood Serv, DNA Reference Lab, British Bone Marrow Registry, Bristol, Avon, England
[2] Welsh Blood Serv, Welsh Transplantat & Immunogenet Lab, Cardiff, S Glam, Wales
[3] Natl Blood Serv, London, England
来源
TISSUE ANTIGENS | 2004年 / 63卷 / 06期
关键词
HLA-A*24020102L; expression variant; haplotype; frequency;
D O I
10.1111/j.0001-2815.2004.00233.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The low-expression allele HLA-A*24020102L was identified on a likely haplotype bearing B*55, Cw*01 during the investigation of nine cases (four families and five unrelated subjects) of HLA-A*24 lacking the A24 specificity. A search was made of 70,007 HLA-A, HLA-B, and HLA-C DNA-based typed largely northwestern European Caucasoid blood donors on the British Bone Marrow Registry and Welsh Bone Marrow Donor Registry panels for phenotypes possessing A*24, B*55, Cw*01. Fifty three were found, and 12 of these were subsequently shown to possess A*24020102L by sequence-based typing or polymerase chain reaction with sequence-specific primers. This indicated that the likely A*24, B*55, Cw*01 haplotype has a frequency of 0.000378 in the UK and that approximately 22.6% of these will possess A*24020102L. Consequently, HLA-A*24020102L, B*55, Cw*01 is a principal A*24020102L-bearing haplotype, and the minimum carriage and gene frequencies of A*24020102L are 0.017% and 0.000086, respectively, in UK blood donors.
引用
收藏
页码:589 / 591
页数:3
相关论文
共 16 条
[1]  
Bunce M., 1997, Tissue Antigens, V50, P100, DOI 10.1111/j.1399-0039.1997.tb02847.x
[2]   A DNA-based detection and screening system for identifying HLA class I expression variants by sequence-specific primers [J].
Bunce, M ;
Procter, J ;
Welsh, KI .
TISSUE ANTIGENS, 1999, 53 (05) :498-506
[3]   An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision [J].
Darke, C .
BONE MARROW TRANSPLANTATION, 2000, 25 (07) :771-777
[4]   Immunogenetic study of a new HLA allele, B*2723 [J].
Darke, C ;
Street, J ;
Hammond, L ;
Downing, J ;
Thompson, J .
TISSUE ANTIGENS, 2002, 60 (05) :400-403
[5]  
De Canck I., 2002, Human Immunology, V63, pS92, DOI 10.1016/S0198-8859(02)00649-3
[6]   Immunogenetics of a new HLA-B null allele, HLA-B*4423N [J].
Hammond, L ;
Street, J ;
Downing, J ;
Thompson, J ;
Darke, C .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 2003, 30 (06) :385-386
[7]  
Imanishi T., 1992, HLA 1991, P1065
[8]   An intronic mutation responsible for a low level of expression of an HLA-A*24 allele [J].
Laforet, M ;
Froelich, N ;
Parissiadis, A ;
Bausinger, H ;
Pfeiffer, B ;
Tongio, MM .
TISSUE ANTIGENS, 1997, 50 (04) :340-346
[9]  
Magor KE, 1997, J IMMUNOL, V158, P5242
[10]   Identification of an HLA-A11 serological variant and its characterization by sequencing based typing [J].
Morrell, G ;
Whalley, J ;
Stewart, A ;
Day, S ;
Lewis, L ;
Makar, Y ;
Fuggle, SV ;
Ross, J ;
Dunn, PPJ .
TISSUE ANTIGENS, 1999, 53 (06) :591-594